Sector portfolio · VC firm · Canada

Lumira Ventures' Biotech portfolio

Lumira Ventures has backed 16 Biotech startups in rounds we track, $985M between them, shown by the stage each has reached. The best-funded is Cardiac Dimensions.

16startups backed
4stages
$985Mraised between them
Series Bbiggest stage

Lumira Ventures's profile

Segment by segment

Series B

6 startups · $541M raised

  1. Cardiac DimensionsCardiac Dimensions is a medical device company based in Kirkland, Washington, founded in 2001.United States$150M
  2. Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M
  3. Antios TherapeuticsAntios Therapeutics is a clinical-stage biopharmaceutical company based in Atlanta, Georgia, founded in 2018.United States$100M
  4. ContralineContraline is a clinical-stage biotechnology company based in Charlottesville, Virginia, founded in 2015.United States$100M
  5. COUR PharmaCOUR Pharma is a clinical-stage biotechnology company based in Skokie, Illinois, focused on developing innovative therapies for auUnited States$50M
  6. Thryv TherapeuticsThryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.Canada$30M

Series C and later

4 startups · $236M raised

  1. ENDOTRONIXEndotronix is a developer of hemodynamic monitoring technologies to help detect worsening heart failure earlier than ever before.United States$119M
  2. BBAROnovaBAROnova is a Silicon Valley based venture-backed company that has developed a novel non-surgical solution for obesity.United States$85M
  3. Exact ImagingExact Imaging is a Canadian MedTech company based in Markham, Ontario, focused on developing high-resolution micro-ultrasound systCanada$16M
  4. AAntivaUnited States$15M

Stage not reported

3 startups · $137M raised

  1. Congruence TherapeuticsCongruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock Goldsmith.Canada$72M
  2. SPSasuma PharmaceuticalsUnited States$62M
  3. GPGladius PharmaceuticalsGladius Pharmaceuticals is a biotechnology firm developing novel drugs to treat life-threateningCanada$3.3M

Series A

3 startups · $71M raised

  1. Specific BiologicsSpecific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.Canada$36M
  2. VPVascular PharmaceuticalsVascular Pharmaceuticals engages in the development of therapeutics targeting the treatment of diabetes associated complications.United States$26M
  3. AmacaTheraAmacaThera is a clinical-stage biotechnology company based in Toronto, Canada.Canada$9.1M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Lumira Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Lumira Ventures?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.